2021-01-03,b'$FBIO $3.17-0.23  -6.76%CUTX-101 Menkes diseaseRolling NDA submission expected to start in 1Q 2021 and to be completed 2Q 2021.\n$IMRA $22.05 +0.72  +3.38%IMR-687 Sickle cell Disease Phase 2a additional data due 1Q 2021.'
2021-01-02,b'$IMRA in Downtrend: Stochastic indicator sits in oversold zone for 4 days. View odds for this and other indicators: https://t.co/4R0SZRbKNC #Imara #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/yNdxygkZ25'
2021-01-01,b'$IMRA in Downtrend: Stochastic indicator stays in oversold zone for 4 days. View odds for this and other indicators: https://t.co/6mwsyW3ZJp #Imara #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/wM1obpMmBf'
2020-12-31,b'50 DMA Support today: $IMRA $FMS ... https://t.co/aW7zteKP9U'
2021-01-08,b'IMARA Inc. Shares Close the Week 31.0% Lower - Weekly Wrap https://t.co/ClVgLWKXQB $IMRA #stockmarket #kwhenfinance'
2021-01-08,b'IMARA Inc. Shares Fall 4.3% Below Previous 52-Week Low - Market Mover https://t.co/L6prOsgTVK $IMRA #stockmarket #kwhenfinance'
2021-01-08,"b""$IMRA's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds for this and other indicators: https://t.co/cuJ5fKMWW3 #Imara #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/dZD0ZfhuXd"""
2021-01-07,"b'$IMRA You can tell a bunch of day traders expected the $IMRA bounce back to happen within 48 hours, and gave up waiting by EOD today. It might be gradual over a few days/weeks, but I am holding on and waiting for it.'"
2021-01-07,"b'Imara reported a mixed bag of phase IIa study data for its lead candidate, IMR-687, for treating sickle cell disease in adults, bringing an end to a study that the company found cumbersome and that eventually stung its stock. $IMRA https://t.co/nnfKOHqESM'"
2021-01-07,"b'Stocks in Top Losers today: $IMRA, Current Price: $14.72, Change today: 0.00%, Total Traded Volume: 0 https://t.co/bq7l8GBg5o'"
2021-01-07,b'Imara declined yesterday as its sickle cell treatment appears to be not at par with its peers $IMRA $BLUE $VRTX $CRSP https://t.co/1CKBxHhvIN'
2021-01-07,b'$IMRA $IMRA $BLUE - Imara declined yesterday as its sickle cell treatment appears to be not at par with its peers https://t.co/omkwAIt9bG'
2021-01-07,b'I got my eye on $IMRA definitely need to do some DD but looks like a perfect long-term swing once it bottoms.'
2021-01-07,"b'VIDEO: U.S. Stock Markets Morning Insights: (21/01/07)\nhttps://t.co/5rdDozdxmc\nFeatured Stocks: $BNGO, $UONE, $ADXS, $CSR, $FMC, $WBAI, $ORTX, $NAKD, $IMRA, $NMTR, $VISL, $AMC, $ATOS, $CYTH, $ARCT ... \n#stocks #stockmarket #stockstowatch #stockinsights'"
2021-01-07,"b""RT @john_bresnahan: @nolastevedore Seems to have once again found it's day in the light, $IMRA seems to be trying something similar to what\xe2\x80\xa6"""
2021-01-07,b'RT @ByMadeleineA: $IMRA disappoints in sickle cell disaese. My quick take via @evaluatevantage https://t.co/60oiFcwzQc'
2021-01-07,"b""@nolastevedore Seems to have once again found it's day in the light, $IMRA seems to be trying something similar to what was tried before... so heaps of risk here.\n\nw/ regards to the others, you've got GTx where I highly suspect the patient pool is much smaller than they let on and new moas....."""
2021-01-07,b'RT @ByMadeleineA: $IMRA disappoints in sickle cell disaese. My quick take via @evaluatevantage https://t.co/60oiFcwzQc'
2021-01-07,"b""Welp I'm on the wrong end of this story but $IMRA will remain in the bio basket (at least) through their 2b data, which is shaping up to be quite the binary event... https://t.co/YyJocDXpmh"""
2021-01-07,b'Imara Reports Phase 2a Clinical Trial Results of IMR-687 in Adult Patients with Sickle Cell Disease $IMRA https://t.co/HDDKOsIUm0'
2021-01-07,"b""Imara's sickle cell treatment shows promising action in mid-stage study $IMRA https://t.co/D4Wo2KKVTi"""
2021-01-07,"b'RT @stocktreats: VIDEO: U.S. Stock Markets Nightly Insights: (21/01/06)\nhttps://t.co/nmewnF0Uzy\nFeatured Stocks: $UONE, $MXC, $TATT, $ANTE,\xe2\x80\xa6'"
2021-01-07,"b""RT @supertrendhq: Today's Top % Losing \xf0\x9f\x93\x89#Stocks:\n\n$IMRA $NAKD $MXC $ONTX $EYES $MYSZ $ATOS $ANTE $ACST $CTRM $SYN $PAVM $CGIX $ADXS $TMDI #\xe2\x80\xa6"""
2021-01-07,"b'VIDEO: U.S. Stock Markets Nightly Insights: (21/01/06)\nhttps://t.co/nmewnF0Uzy\nFeatured Stocks: $UONE, $MXC, $TATT, $ANTE, $ATOS, $WBAI, $ISR, $ONTX, $DGLY, $IMRA, $ORTX, $UUU, $MYSZ, $CTRM, $NCTY ... \n#stocks #stockmarket #stockstowatch #stockinsights'"
2021-01-07,"b""RT @supertrendhq: Today's Top % Losing \xf0\x9f\x93\x89#Stocks:\n\n$IMRA $NAKD $MXC $ONTX $EYES $MYSZ $ATOS $ANTE $ACST $CTRM $SYN $PAVM $CGIX $ADXS $TMDI #\xe2\x80\xa6"""
2021-01-07,"b""Today's Top % Losing \xf0\x9f\x93\x89#Stocks:\n\n$IMRA $NAKD $MXC $ONTX $EYES $MYSZ $ATOS $ANTE $ACST $CTRM $SYN $PAVM $CGIX $ADXS $TMDI #SuperTrend"""
2021-01-07,b'Wed Jan 6\nLosing #stocks today:\n\n$IMRA: -38.0%\n$SGTX: -11.4%\n$RMED: -9.6%\n$PLG: -8.6%\n$BAND: -8.4%\n$PAND: -8.3%\n$BTBT: -8.1%\n$WNW: -8.1%\n$AVLR: -8.0%\n\nclick here for a visual version:\nhttps://t.co/53r4V5ziMC https://t.co/5C0e9vY3RQ'
2021-01-07,b'Top 5 Oversold Stocks - Brought to you by Arcadiatrading team:\n\n1.  $IMRA -37.97%\n2. $NAKD -24.90%\n3. $MXC -23.83%\n4. $EYES -21.08%\n5. $MYSZ -20.71%\n\nUp 443.8% in closed positions in the last 28 trading days. Up 98.2% on ... https://t.co/pfsRZ0EbrO https://t.co/kigRWPWcnZ'
2021-01-06,b'Biopharma Daily Stock Updates - 01/06/20\n$XBI $143.32 (+2.04%) \xf0\x9f\x93\x88\n\nPIPELINE:\n$IMRA (-37.97%) - Ph 2a Results\n$RDHL (-3.76%) - Fast Track\n$RDUS (+15.76%) - Acquisition\n$SELB (+8.22%)  - Data\n$ZNTL (-6.54%) - Initiation\n\nFINANCE:\n$RGNX (+8.39%) - Offering\n\nhttps://t.co/kM84hB4YrB'
2021-01-06,b'RT @thestinkmarket: I just went all in ($22.69) on $IMRA. Down 33% this morning. No idea what this company does. Can\xe2\x80\x99t wait to become a tri\xe2\x80\xa6'
2021-01-06,b'Imara Analyst Says Buy The Weakness Ahead Of Multiple 2021 Data Readouts $IMRA https://t.co/NyvevKX2MV'
2021-01-06,b'US Top Losers\n$IMRA -37.970% (BIOTECH)\n$NAKD -24.900%\n$MXC -23.830%\n$ONTX -21.690%\n$EYES -21.080%\n #stocks #stockmarket #stockstowatch'
2021-01-06,"b""RT @Mazeraski: It's a wrap - Biotech Advancers/Decliners\nAdv: $ISR $ORTX $NMTR $DBVT $GHSI $NRBO $ONVO $CYTR $RDUS $INBX\nDec: $IMRA $ONTX $\xe2\x80\xa6"""
2021-01-06,b'Top Losers today:\n\n$IMRA -37.97%\n$NAKD -24.90%\n$MXC -23.83%\n$EYES -21.08%\n$MYSZ -20.71%\n\n#toplosers #trading #NYSE'
2021-01-06,"b""It's a wrap - Biotech Advancers/Decliners\nAdv: $ISR $ORTX $NMTR $DBVT $GHSI $NRBO $ONVO $CYTR $RDUS $INBX\nDec: $IMRA $ONTX $ATOS $SYN $ACST $PAVM $ADXS $NVIV $AVGR $NSPR https://t.co/EovQSkR6HB"""
2021-01-06,"b""Today's Top 5 Decliners Report:\n$IMRA (-38%)\n$IGZ (-28%)\n$MXC (-24%)\n$IBO (-24%)\n$NAKD (-23%)\n\nAlerts, Charts, and Technical Analysis via https://t.co/Qkw92RLxV8\n#daytrading #stocks"""
2021-01-06,b'$IMRA in around 14.44 out at 14.65'
2021-01-06,b'Wed Jan 6\nLosing #stocks this afternoon:\n\n$IMRA: -36.6%\n$GBIO: -8.0%\n$BILL: -7.0%\n$NEO: -6.8%\n$PAND: -6.6%\n$AVLR: -6.4%\n$BAND: -6.3%\n$MTNB: -6.2%\n\nclick here for a visual version:\nhttps://t.co/naJeM3Q72c https://t.co/PpIkCC2ZJT'
2021-01-06,b'RT @MarketChmln: Top Stock Gainers $TATT $NCTY $ORTX $CBAT $CHNG Top Stock Decliners $IMRA $MXC $FAZ $TZA $SGTX https://t.co/cMFgZFIhQ6'
2021-01-06,"b""Fly Intel: Wall Street's top stories at midday $MRNA $CHA $CHL $CHU $ABC $WBA $UNH $CHNG $TSLA $GTH $DNMR $IMRA $NEO https://t.co/e98pgQTBUR"""
2021-01-06,b'RT @Mazeraski: Mid-day Biotech Advancers/Decliners\nAdv: $ISR $NMTR $GHSI $OGEN $NRBO $ORTX $XBIO $ONVO $DBVT $SESN\nDec: $IMRA $ATOS $SYN $O\xe2\x80\xa6'
2021-01-06,b'Buying opportunity $IMRA'
2021-01-06,b'Mid-day Biotech Advancers/Decliners\nAdv: $ISR $NMTR $GHSI $OGEN $NRBO $ORTX $XBIO $ONVO $DBVT $SESN\nDec: $IMRA $ATOS $SYN $ONTX $BBI $PAVM $HROW $CLSD $ALRN $AVGR https://t.co/j32ZLDikrS'
2021-01-06,b'Today\xe2\x80\x99s Top % Losers:\n\n\xe2\x9e\xa1\xef\xb8\x8f NASDAQ: $IMRA $EYES $MYSZ $ATOS $NKD\n\xe2\x9e\xa1\xef\xb8\x8f NYSE: $BNKD $HIBS $MTR $NRGD $BILL\n\xe2\x9e\xa1\xef\xb8\x8f AMEX: $MXC $SYN $AINC $ZOM $NSPR\n\xe2\x9e\xa1\xef\xb8\x8f OTC: $ICNM $GARB $USRM $ARSC $GHST https://t.co/Vjw22ZYs7L'
2021-01-06,"b'Mid-Day Top 5 Decliners Report:\n$IMRA (-36%)\n$IGZ (-28%)\n$IBO (-24%)\n$EYES (-22%)\n$MXC (-21%)\n\nAlerts, Charts, and Technical Analysis via https://t.co/Qkw92RLxV8\n#daytrading #stocks'"
2021-01-06,"b'$IMRA regardless of interpretation of the recent results. Any stock drops 35% to its lowest while still having a change at success, should see some bounce back. Buying opportunity. \xf0\x9f\xa4\xb7\xf0\x9f\x8f\xbe\xe2\x80\x8d\xe2\x99\x82\xef\xb8\x8f'"
2021-01-06,b'Top Stock Gainers $TATT $NCTY $ORTX $CBAT $CHNG Top Stock Decliners $IMRA $MXC $FAZ $TZA $SGTX https://t.co/cMFgZFIhQ6'
2021-01-06,b'RT @ByMadeleineA: $IMRA disappoints in sickle cell disaese. My quick take via @evaluatevantage https://t.co/60oiFcwzQc'
2021-01-06,b'$IMRA disappoints in sickle cell disaese. My quick take via @evaluatevantage https://t.co/60oiFcwzQc'
2021-01-06,b'Trending stocks from https://t.co/0RWVE5AKlY \n$GHSI +0.31 (+55.67%) \n$AIKI +0.47 (+54.92%) \n$TATT +2.25 (+44.12%) \n$CHNG +5.67 (+31.11%) \n$NMTR +0.30 (+28.04%) \n$ISR +0.98 (+184.64%) \n$IMRA -8.08 (-34.05%) \n$SYN -0.24 (-24.50%) \n$ATOS -0.24 (-20.79%)'
2021-01-06,"b'Imara selloff a potential buying opportunity, says SVB Leerink\n$IMRA'"
2021-01-06,b'$IMRA stock declines -33.4%. View latest news. https://t.co/5sNwHqcwxZ'
2021-01-06,"b'(Heavy Volumes at 10x normal) $IMRA(IMARA Inc.) trading at $15.2, change today = -34.72% https://t.co/0PwJCf4mnV'"
2021-01-06,b'Wed Jan 6\nLosing #stocks this morning:\n\n$IMRA: -35.6%\n$SGTX: -11.0%\n$WNW: -7.5%\n$NEO: -7.0%\n$INFN: -6.8%\n$GSHD: -6.7%\n$U: -6.4%\n$ORLA: -5.9%\n\nclick here for a visual version:\nhttps://t.co/2iMm0bFCLX https://t.co/XQ3Mk1aIUq'
2021-01-06,b'#NYSE\xc2\xa0\xf0\x9f\x87\xba\xf0\x9f\x87\xb8\xc2\xa0Top\xc2\xa0Three\nGainers\n$DNMR \xe2\x86\x912.86\xe2\x86\x9225.62\n$HEXO \xe2\x86\x910.50\xe2\x86\x924.65\n$SOL \xe2\x86\x911.77\xe2\x86\x9216.49\nLosers\n$IMRA \xe2\x86\x938.33\xe2\x86\x9215.40\n$BPT \xe2\x86\x930.21\xe2\x86\x922.67\n$GBX \xe2\x86\x932.55\xe2\x86\x9233.41\n[price\xc2\xa0\xe2\x89\xa5\xc2\xa020\xc2\xa2] [volume\xc2\xa0\xe2\x89\xa5\xc2\xa010k] [delayed\xc2\xa015\xc2\xa0minutes]\n#Gainers #Losers #USMarkets\nVisit:\xc2\xa0https://t.co/YnZ3SKqXcm'
2021-01-06,"b'Stocks in Top Losers today: $IMRA, Current Price: $15.35, Change today: -33.40%, Total Traded Volume: 185,987 https://t.co/lG5dBNUinu'"
2021-01-06,b'I just went all in ($22.69) on $IMRA. Down 33% this morning. No idea what this company does. Can\xe2\x80\x99t wait to become a trillionaire. https://t.co/1BVhyt5OtT'
2021-01-06,b'$IMRA Imara Reports Phase 2a Clinical Trial Results of IMR-687 in Adult Patients with Sickle Cell Disease https://t.co/iiFCGmyEPp'
2021-01-06,"b""@avidresearch @john_bresnahan $IMRA reduction in retics suggests they are protecting existing RBCs. Holding RBC counts constant you'd expect that to reduce VoC.\n\nBut Q is not whether drug is better than nothing. Q is if it's competitive. I think obviously not."""
2021-01-06,b'$IMRA #Imara declines in premarket trading. See the latest news. https://t.co/moMedEc8Xe https://t.co/hqNr8av9Xz'
2021-01-06,b'@john_bresnahan @brendan_49 odd that other drugs ($GBT) have good Hb data but modest VOC  while $IMRA seems to generate decent VOC data consistently but HbF HB data meh..'
2021-01-06,"b'In Play: $AIKI, $NRBO, $ATIF, $IMRA, $NMTR, $ISR, $ENSV, $SCYX  High Uncertainty: $GM, $MJ, $BEEM'"
2021-01-06,b'RT @Briefingcom: $IMRA: IMARA reported results from its Phase 2a clinical trial of IMR-687 in adult patients with sickle cell disease https\xe2\x80\xa6'
2021-01-06,b'$IMRA: IMARA reported results from its Phase 2a clinical trial of IMR-687 in adult patients with sickle cell disease https://t.co/ylO1JfWekx'
